Vanguard Group Inc Edwards Lifesciences Corp Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 70,363,210 shares of EW stock, worth $6.07 Billion. This represents 0.08% of its overall portfolio holdings.

Number of Shares

70,363,210

Previous 69,997,629 0.52%

Holding current value

$6.07 Billion

Previous $5.47 Billion 0.04%

% of portfolio

0.08%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$73.75 - $81.83 $27 Million - $29.9 Million	365,581 Added 0.52%	70,363,210 $5.47 Billion
Q2 2025 Aug 11, 2025	BUY	$67.07 - $78.22 $53.6 Million - $62.5 Million	798,801 Added 1.15%	69,997,629 $5.47 Billion
Q1 2025 May 09, 2025	BUY	$67.95 - $76.19 $4.54 Million - $5.09 Million	66,792 Added 0.1%	69,198,828 $5.02 Billion
Q4 2024 Feb 11, 2025	BUY	$64.54 - $75.92 $422 Million - $496 Million	6,537,494 Added 10.44%	69,132,036 $5.12 Billion
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $538 Million - $846 Million	9,018,528 Added 16.83%	62,594,542 $4.13 Billion
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $51.6 Million - $57.7 Million	611,620 Added 1.15%	53,576,014 $4.95 Billion
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $43.6 Million - $57.4 Million	600,994 Added 1.15%	52,964,394 $5.06 Billion
Q4 2023 Mar 11, 2024	BUY	$61.71 - $77.76 $30,052 - $37,869	487 Added 0.0%	52,363,400 $3.99 Billion
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $45 Million - $56.7 Million	729,497 Added 1.41%	52,362,913 $3.99 Billion
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $22.6 Million - $30.4 Million	325,808 Added 0.64%	51,633,416 $3.58 Billion
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $36.1 Million - $41.8 Million	-443,619 Reduced 0.86%	51,307,608 $4.84 Billion
Q1 2023 Jul 14, 2023	BUY	$74.26 - $84.51 $29,109 - $33,127	392 Added 0.0%	51,751,227 $4.28 Billion
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $14.2 Million - $16.2 Million	191,444 Added 0.37%	51,750,835 $4.28 Billion
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $44.3 Million - $56.7 Million	648,287 Added 1.27%	51,559,391 $3.85 Billion
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $49.8 Million - $64.8 Million	604,269 Added 1.2%	50,911,104 $4.21 Billion
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $50.3 Million - $74.6 Million	581,969 Added 1.17%	50,306,835 $4.78 Billion
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $66.1 Million - $83.2 Million	648,217 Added 1.32%	49,724,866 $5.85 Billion
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $28.7 Million - $35.3 Million	269,987 Added 0.55%	49,076,649 $6.36 Billion
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $51.2 Million - $61 Million	497,212 Added 1.03%	48,806,662 $5.53 Billion
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $4.05 Billion - $5.06 Billion	48,309,450 New	48,309,450 $5 Billion

Others Institutions Holding EW

# of Institutions

1,457

Shares Held

468M

Call Options Held

3.49M

Put Options Held

4.09M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Edwards Lifesciences Corp Transaction History